Suchergebnisse - "KE CHANGWEN"

PubPharm (10)

1

Potent Antibody Response Elicited by a Third Booster Dose of Inactivated COVID-19 Vaccine in Healthy Subjects

enthalten in: Viral immunology | 2023

von Ji, R. | Zhang, J. | Liang, D. | +9

2

The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody

enthalten in: Frontiers in cellular and infection microbiology | 2023

von Li, Y. | He, J. | Zhang, Y. | +9

3

Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection

enthalten in: Emerging microbes & infections | 2022

von Liang, H. | Zheng, P. | Wang, Q. | +16

4

A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates

enthalten in: Emerging microbes & infections | 2022

von An, Y. | Li, S. | Jin, X. | +25

5

A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2

enthalten in: Cell reports | 2022

von Yuan, Y. | Zhang, X. | Chen, R. | +22

6

Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates

enthalten in: ACS nano | 2021

von Kang, Y. | Sun, C. | Zhuang, Z. | +18

7

Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects

enthalten in: Frontiers in cellular and infection microbiology | 2021

von Zhang, J. | Xing, S. | Liang, D. | +18

8

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

enthalten in: Nature communications | 2020

von Feng, L. | Wang, Q. | Shan, C. | +28

9

Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection

enthalten in: Chemical communications (Cambridge, England) | 2020

von Qi, X. | Ke, B. | Feng, Q. | +7

10

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

enthalten in: Cell | 2020

von Dai, L. | Zheng, T. | Xu, K. | +18

1
[1]